Conference - San Diego, CA, United States
This conference offers a unique mix of engaging sessions and topics focused on the research and drug discovery of male specific oncology.The conference includes keynote addresses from representatives from big pharma, academic institutions and government research labs who will present data and case studies on key topics such as prostate cancer diagnostics and therapeutics, PARP inhibitors, prostate cancer genetics and genomics and Immuno-oncology therapy. Attend to learn and network with key opinion leaders in a highly interactive and intimate environment, benefiting from the exclusive insights of our faculty of senior industry speakers and renowned topic experts and academia. 2014 Session Topics: I. Prostate Cancer - Diagnostics and Early Detection II. Genomics and Prostate Cancer III. Advances for Overcoming Drug Resistance IV. Clinical Advances in Male Cancer Therapy V. Rare Male Cancers Panel Discussion: Therapy and PSA Levels - Are we too aggressive in treating patients based solely on elevated PSA levels? General Session (both tracks) I. Advances in Gender Neutral Immuno-Oncology Therapy II. Advances in Gender Neutral Diagnostic/Detection Strategies III. Clinical Advances in PARP Inhibitors
Organizer: Global Technology Community (GTC) www.gtcbio.com
For more information, please visit: https://www.gtcbio.com/conferences/male-cancer-research-drug-discovery-overview
November 6, 2014 - November 7, 2014 (08:00 - 15:00)
Hyatt Regency Mission Bay San Diego
1404 Vacation Road, San Diego, California 91016, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
